Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Neuroprotective action of Cortexin, Cerebrolysin and Actovegin in acute or chronic brain ischemia in rats.
Kurkin DV, Bakulin DA, Morkovin EI, Kalatanova AV, Makarenko IE, Dorotenko AR, Kovalev NS, Dubrovina MA, Verkholyak DV, Abrosimova EE, Smirnov AV, Shmidt MV, Tyurenkov IN. Kurkin DV, et al. Among authors: makarenko ie. PLoS One. 2021 Jul 14;16(7):e0254493. doi: 10.1371/journal.pone.0254493. eCollection 2021. PLoS One. 2021. PMID: 34260655 Free PMC article.
Clinical Pharmacology of Insulin Aspart Biosimilar GP40071: Pharmacokinetic/Pharmacodynamic Comparability in Hyperinsulinemic Euglycemic Clamp Procedure.
Drai RV, Karonova TL, Mayorov AY, Makarenko IE, Dorotenko AR, Kulesh VS, Kovalik VV, Andreeva AT. Drai RV, et al. Among authors: makarenko ie. Clin Pharmacol Drug Dev. 2022 Aug;11(8):922-929. doi: 10.1002/cpdd.1084. Epub 2022 Mar 1. Clin Pharmacol Drug Dev. 2022. PMID: 35230749 Free PMC article. Clinical Trial.
The efficacy and safety of GP40081 (insulin aspart biphasic 30) compared with NovoMix® 30 in Type 2 diabetes patients.
Drai RV, Mayorov AY, Karonova TL, Parfenova TM, Makarenko IE, Magruk MA, Alpenidze DN, Kovalik VV, Zinnatulina BR, Grigorjeva IV, Andreeva AT. Drai RV, et al. Among authors: makarenko ie. J Comp Eff Res. 2022 Dec;11(18):1337-1347. doi: 10.2217/cer-2021-0232. Epub 2022 Dec 13. J Comp Eff Res. 2022. PMID: 36511777 Free article. Clinical Trial.
A randomized, double-blind, comparative study of the pharmacodynamics and pharmacokinetics of GP40141 (romiplostim biosimilar) and reference romiplostim in healthy male volunteers.
Makarenko I, Dorotenko A, Noskov S, Banko V, Saparova V, Khokhlov A, Zoreeva E, Nedorubov A, Zinnatulina B, Gefen M, Drai R. Makarenko I, et al. Pharmacol Res Perspect. 2023 Oct;11(5):e01125. doi: 10.1002/prp2.1125. Pharmacol Res Perspect. 2023. PMID: 37740581 Free PMC article. Clinical Trial.
16 results